Changes in pathogen spectrum and antimicrobial resistance development in the time-course of acute necrotizing pancreatitis.

Antimicrobial treatment of infected pancreatic necrosis becomes more challenging over time, owing to a change in spectrum favoring difficult-to-treat pathogens and an increase in multi-resistant bacteria associated with worse clinical outcomes (World Health Organization trial registration number: DRKS00014785).